Flossbach Von Storch »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Flossbach Von Storch

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Flossbach Von Storch from 13F filings

Historical chart of Flossbach Von Storch investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Flossbach Von Storch consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Flossbach Von Storch

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.7M 1.4M 1.19
2024-06-30 $2.0M 1.8M 1.12
2024-03-31 $2.5M 2.5M 0.98
2023-12-31 $2.4M 2.5M 0.94
2023-09-30 $2.4M 2.5M 0.94

More positions owned by Flossbach Von Storch

Berkshire Hathaway (BRK.B)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Apple (AAPL)
Johnson & Johnson (JNJ)
Danaher Corporation (DHR)
Abbott Laboratories (ABT)
Fortive (FTV)
Pepsi (PEP)
Thermo Fisher Scientific (TMO)
Intercontinental Exchange (ICE)
Amphenol Corporation (APH)
Visa (V)
Charles Schwab Corporation (SCHW)

View all positions for Flossbach Von Storch

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1